Considering the efficacy, safety, and tolerability factors in determining the appropriate antiretroviral components for your patient’s initial HAART regimen?

This tool enables you to review data from controlled studies on the DHHS and IAS-USA preferred antiretroviral regimens for initial antiretroviral therapy. You can also view a convenient graphical summary of the key data from those studies and print the data and/or download corresponding slides.